← Open Payments lookup

KEEGAN WOOD: Open Payments

NPI 1417471459 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$744 in 33 payments from 8 companies in 2025. Trend: 2023 $1,649 · 2024 $1,388 · 2025 $744

Food & beverage: $744
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.9$190
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$160
Vanda Pharmaceuticals Inc.3$110
Alkermes, Inc.5$87
Teva Pharmaceuticals USA, Inc.3$66
Neurocrine BioSciences, Inc.2$55
ABBVIE INC.2$46
Janssen Pharmaceuticals, Inc2$29

Products named: CAPLYTA, REXULTI, FANAPT, ARISTADA, INGREZZA, ABILIFY ASIMTUFII, AUSTEDO XR, VRAYLAR.

Industry payments across CA — which companies pay providers there.